GSK plc (BCBA:GSK)

Market Cap	97.54T
Revenue (ttm)	43.71T
Net Income (ttm)	4.37T
Shares Out	n/a
EPS (ttm)	1,055.37
PE Ratio	22.31
Forward PE	8.26
Dividend	382.63 (3.18%)
Ex-Dividend Date	May 16, 2025

Volume	47
Average Volume	314
Open	12,250
Previous Close	12,150
Day's Range	12,075 - 12,325
52-Week Range	9,110 - 14,400
Beta	n/a
RSI	60.17
Earnings Date	Jul 28, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a...

• Industry: Pharmaceutical Preparations
• Founded: 1715
• Employees: 68,629
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: GSK

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP